Navigation Links
NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System for the Treatment of Drug-Resistant Epilepsy and Major Depressive Disorder
Date:5/2/2013

University of Southern California (USC). After 18 weeks of eTNS therapy, 40.5% of patients in the treatment group had a reduction in seizures of at least 50%. In addition to clinical trials in epilepsy, NeuroSigma has funded clinical trials at UCLA for the treatment of major depression, PTSD and ADHD.

The Monarch eTNS System will be sold by prescription in Canada to patients under physician supervision.  The system is composed of an external pulse generator and disposable external electric patches placed on the forehead that are replaced daily. The patches are worn primarily in the evening while asleep. 

"We are very pleased to have received the license from Health Canada," said Leon Ekchian, Ph.D., President and CEO of NeuroSigma.  "It is another major milestone for NeuroSigma in the commercialization of trigeminal nerve stimulation and enables us to work with a new physician population and their patients.  We are committed to making eTNS affordable and available worldwide."

"I am delighted as an inventor that this therapy is now available to physicians and patients in Canada," added Christopher DeGiorgio , M.D., Vice President of Neurology and Professor of Neurology at UCLA. "In the United States, we have completed our pre-IDE meeting with the FDA and are preparing our IDE submission to commence a multi-center pivotal trial of eTNS for epilepsy.  Over twenty-five major epilepsy centers have expressed strong interest in being part of this trial."

"As a psychiatrist, I'm excited to see that this new treatment paradigm will be available to physicians in Canada to address the unmet needs for their patients with depression," added Ian Cook , M.D., Director of the UCLA Depression Research & Clinic Program and Senior Medical Advisor to NeuroSigm
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
2. NeuroSigma Awarded Fast Track SBIR Grant by the NIH for Development of Implantable sTNS System for Drug Resistant Epilepsy
3. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
4. NeuroSigma Receives CE Certification
5. NeuroSigma Receives Global Quality Control Certification
6. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
7. Scioderms SD-101 Receives Breakthrough Therapy Designation from FDA for Treatment of Epidermolysis Bullosa
8. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
9. drchrono Receives Investment from Box
10. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
11. iBio, Inc. receives Notice from NYSE MKT Staff that Company currently is not in compliance with an additional Continued Listing Standard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... BOSTON , January 23, 2015 ... development company, is delighted to announce that the Malcolm ... Miles Congreve (Vice President of Chemistry), Fiona ... Weir (Chief Executive Officer and co-founder) for the seminal ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... One of the fastest-growing specialties in oncology healthcare ... professional needs. Cold Spring Publishing, LLC, is pleased to ... Oncology, a publication for nurse practitioners, clinical nurse ... in the field of oncology . , ...
... Oct. 8 The most comprehensive, up-to-date compendium ... is now available from Point of Care Partners ... (HIT) strategy and management consulting firm with expertise ... health information exchanges and personal health records. , ...
Cached Medicine Technology:Cold Spring Publishing Announces the Launch of a New Oncology Publication: The Journal of the Advanced Practitioner in Oncology 2Cold Spring Publishing Announces the Launch of a New Oncology Publication: The Journal of the Advanced Practitioner in Oncology 3Newly Updated Pharmacy State Law Compendium Available 2
(Date:1/22/2015)... LunaDress, with its top dressmaking technologies, has been ... business is showing its latest designs of wedding dresses and ... the company’s CEO, all the fresh new products are designed ... up to 80% off. All the clothes from LunaDress follow ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... a Patient-Centered Medical Home Popular with Patients and ... of Ontario,s Family Health Team Model, which serves ... largest example of a patient-centered medical home. Implemented ... based on multidisciplinary teams and an innovative incentive-based ...
... MONDAY, March 14 (HealthDay News) -- Stroke survivors, even ... be independent if they are depressed, older, or have other ... stroke survivors, average age 62, who had no severe language ... with depression one month after their stroke. The patients, ...
... HealthDay Reporter , MONDAY, March 14 (HealthDay News) ... and use physical punishment, even on tots who are still ... 1-year-olds found they were more likely to spank and less ... The finding adds more weight to the emerging awareness of ...
... By Alan Mozes HealthDay Reporter , MONDAY, ... -- and the abundance of omega-3 fatty acids found in ... age-related macular degeneration (AMD), new research suggests. This latest ... health mirrors past research that has found the same benefit. ...
... Goodwin HealthDay Reporter , MONDAY, March 14 (HealthDay News) ... pediatrician or nurse they see regularly who offers comprehensive care -- ... new research finds. Yet it,s the sickest children -- those ... most care -- who are less likely to get the sort ...
... In a research study appearing in the journal Cancer ... Laboratory (CSHL) and four other institutions have identified a strategy ... limited treatment options and one of the worst one-year survival ... up to 15% of liver tumors are "driven" by the ...
Cached Medicine News:Health News:March/April 2011 Annals of Family Medicine tip sheet 2Health News:March/April 2011 Annals of Family Medicine tip sheet 3Health News:March/April 2011 Annals of Family Medicine tip sheet 4Health News:March/April 2011 Annals of Family Medicine tip sheet 5Health News:March/April 2011 Annals of Family Medicine tip sheet 6Health News:March/April 2011 Annals of Family Medicine tip sheet 7Health News:March/April 2011 Annals of Family Medicine tip sheet 8Health News:Depression Threatens Independence of Stroke Survivors 2Health News:Depressed Dads More Likely to Spank, Shortchange Kids: Study 2Health News:Depressed Dads More Likely to Spank, Shortchange Kids: Study 3Health News:Eating Fish Might Protect Your Eyesight 2Health News:Eating Fish Might Protect Your Eyesight 3Health News:'Medical Homes' Help Kids Get Comprehensive Care 2Health News:'Medical Homes' Help Kids Get Comprehensive Care 3Health News:Study identifies therapeutic target for liver cancer and predictive biomarker of response 2Health News:Study identifies therapeutic target for liver cancer and predictive biomarker of response 3
... The new E300 Corneal ... diverse range of clinical procedures ... Refractive Surgery and Contact Lens ... compact cone design, the E300 ...
Stainless Steel. Box of 1, non sterile...
... ,Siemens has combined, for the first time, a ... 125 cm magnet and a powerful performance of ... MR. And MAGNETOM Espree, has the power of ... which means faster, more precise results, no patient ...
... upgrade including fourSight 4D ultrasound imaging technology ... a wide variety of imaging and workflow ... that combine to expand the clinical capabilities ... system was built on four foundations that ...
Medicine Products: